(Q38179489)

30 August 2017

title

Immunological milieu in mycosis fungoides and Sézary syndrome (English)

1 reference

30 August 2017

1 reference

1 reference

Tomomitsu Miyagaki

1

1 reference

30 August 2017

Makoto Sugaya

series ordinal

2

1 reference

30 August 2017

publication date

1 January 2014

1 reference

The Journal of Dermatology

30 August 2017

published in

1 reference

30 August 2017

volume

41

1 reference

30 August 2017

issue

1

1 reference

30 August 2017

page(s)

11-18

1 reference

WHO-EORTC classification for cutaneous lymphomas

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Mycosis fungoides and Sézary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Cell cycle deregulation in B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Influence of the microenvironment on melanoma cell fate determination and phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Lymphoma microenvironment: culprit or innocent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

The microenvironment in follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Chemokines: immunology's high impact factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Chemokines and cutaneous lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Chemokine receptor expression by leukemic T cells of cutaneous T-cell lymphoma: clinical and histopathological correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Presence of circulating CCR10+ T cells and elevated serum CTACK/CCL27 in the early stage of mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Aberrant Cytokine Production By Sezary Syndrome Patients: Cytokine Secretion Pattern Resembles Murine Th2 Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Sézary syndrome, T-helper 2 cytokines and accessory factor-1 (AF-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

The microenvironment of the tumour-host interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Increased serum thymic stromal lymphopoietin levels in patients with cutaneous T cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

CCL1-CCR8 Interactions: An Axis Mediating the Recruitment of T Cells and Langerhans-Type Dendritic Cells to Sites of Atopic Skin Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

The origin and function of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Tumour-educated macrophages promote tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Cancer and the chemokine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Alternative activation of macrophages: mechanism and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Macrophage diversity enhances tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Identification and manipulation of tumor associated macrophages in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

The dendritic cell-specific CC-chemokine DC-CK1 is expressed by germinal center dendritic cells and attracts CD38-negative mantle zone B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Unique regulation of CCL18 production by maturing dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Up-regulation of the chemokine CCL18 by macrophages is a potential immunomodulatory pathway in cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Differentiation and functional analysis of human T(H)17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

T helper 17 cell heterogeneity and pathogenicity in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

The many faces of Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

The role of IL-22 and Th22 cells in human skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

CD8+ Sézary syndrome with interleukin-22 production modulated by bacterial sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

The mast cell in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Mast cells and immunoregulation/immunomodulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Mast cells, angiogenesis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Mast cells have a protumorigenic role in human thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Mast cells play a protumorigenic role in primary cutaneous lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Bone marrow angiogenesis and progression in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Increased angiogenesis in cutaneous T-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Vascular endothelial growth factor: basic science and clinical progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Angiogenin: a review of the pathophysiology and potential clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Vascular-specific growth factors and blood vessel formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Pruritus in cutaneous T-cell lymphomas: frequent, often severe and difficult to treat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Erythrodermic cutaneous T-cell lymphoma: how to differentiate this rare disease from atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Significant impact of cutaneous T-cell lymphoma on patients' quality of life: results of a 2005 National Cutaneous Lymphoma Foundation Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

The nerve growth factor 35 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Nocturnal itch: why do we itch at night?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Association of nerve growth factor, chemokine (C-C motif) ligands and immunoglobulin E with pruritus in cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

IL-31: a new link between T cells and pruritus in atopic skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

IL-31 is produced by the malignant T-cell population in cutaneous T-Cell lymphoma and correlates with CTCL pruritus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12305

21 January 2018

Identifiers

DOI

10.1111/1346-8138.12305

1 reference

30 August 2017

1 reference